
    
      Patients with a history of Hypoparathyroidism will be enrolled to receive study drug for up
      to 80 months, which will be injected daily in either thigh. During that time they will be
      monitored for safety (specifically calcium levels in blood or urine). In addition, the
      patients' intake of Vitamin D and Calcium will be measured.
    
  